SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

NCT05631262 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Selected Subjects With Advanced Solid Tumors

Interventions

DRUG: SKB264
DRUG: Docetaxel

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.